艾通立
拼音:àitōnglì藥品說明書:成分:重組組織型纖溶酶原激活劑適應症:急性冠狀動脈栓塞的溶栓療法。用量用法:一般使用量爲100mg,在3hr內靜脈注入。其中10mg在頭1-2分鐘內靜脈注入,其後60分鐘內靜脈滴注50mg,最後40mg在120分...
愛通立
...纖維蛋白溶酶原激活劑;重組組織型纖溶酶原激活劑;愛通立;HumanTissuePlasminogenActivator;Acetivase;Alteplase;G-11021;G-11021(Z-ChainForm);tissue-typeplasminogenactivator;t-PA;Plasvata;rt-PA分類:循環系統藥物抗血栓藥物溶栓劑劑型:20mg...
阿太普酶
...纖維蛋白溶酶原激活劑;重組組織型纖溶酶原激活劑;愛通立;HumanTissuePlasminogenActivator;Acetivase;Alteplase;G-11021;G-11021(Z-ChainForm);tissue-typeplasminogenactivator;t-PA;Plasvata;rt-PA分類:循環系統藥物抗血栓藥物溶栓劑劑型:20mg...
阿特普酶
...纖維蛋白溶酶原激活劑;重組組織型纖溶酶原激活劑;愛通立;HumanTissuePlasminogenActivator;Acetivase;Alteplase;G-11021;G-11021(Z-ChainForm);tissue-typeplasminogenactivator;t-PA;Plasvata;rt-PA分類:循環系統藥物抗血栓藥物溶栓劑劑型:20mg...
G-11021
...纖維蛋白溶酶原激活劑;重組組織型纖溶酶原激活劑;愛通立;HumanTissuePlasminogenActivator;Acetivase;Alteplase;G-11021;G-11021(Z-ChainForm);tissue-typeplasminogenactivator;t-PA;Plasvata;rt-PA分類:循環系統藥物抗血栓藥物溶栓劑劑型:20mg...
組織纖溶酶原激活劑
...纖維蛋白溶酶原激活劑;重組組織型纖溶酶原激活劑;愛通立;HumanTissuePlasminogenActivator;Acetivase;Alteplase;G-11021;G-11021(Z-ChainForm);tissue-typeplasminogenactivator;t-PA;Plasvata;rt-PA分類:循環系統藥物抗血栓藥物溶栓劑劑型:20mg...
阿替普酶
...纖維蛋白溶酶原激活劑;重組組織型纖溶酶原激活劑;愛通立;HumanTissuePlasminogenActivator;Acetivase;Alteplase;G-11021;G-11021(Z-ChainForm);tissue-typeplasminogenactivator;t-PA;Plasvata;rt-PA分類:循環系統藥物抗血栓藥物溶栓劑劑型:20mg...
藥物;血液系統藥物;纖維蛋白溶解藥rt-PA
...纖維蛋白溶酶原激活劑;重組組織型纖溶酶原激活劑;愛通立;HumanTissuePlasminogenActivator;Acetivase;Alteplase;G-11021;G-11021(Z-ChainForm);tissue-typeplasminogenactivator;t-PA;Plasvata;rt-PA分類:循環系統藥物抗血栓藥物溶栓劑劑型:20mg...
循環系統藥物;抗血栓藥物;溶栓劑;血液系統藥物;西藥中毒組織纖維蛋白溶酶原激活劑
...纖維蛋白溶酶原激活劑;重組組織型纖溶酶原激活劑;愛通立;HumanTissuePlasminogenActivator;Acetivase;Alteplase;G-11021;G-11021(Z-ChainForm);tissue-typeplasminogenactivator;t-PA;Plasvata;rt-PA分類:循環系統藥物抗血栓藥物溶栓劑劑型:20mg...
重組組織型纖維蛋白溶酶原激活劑
...纖維蛋白溶酶原激活劑;重組組織型纖溶酶原激活劑;愛通立;HumanTissuePlasminogenActivator;Acetivase;Alteplase;G-11021;G-11021(Z-ChainForm);tissue-typeplasminogenactivator;t-PA;Plasvata;rt-PA分類:循環系統藥物抗血栓藥物溶栓劑劑型:20mg...